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A. ANTIGENS, CHEMISTRY, AND ORIGIN 
1) Antigens: Any foreign substances that elicit the immune response by stimulating 
the production of antibodies and combing with these specific antibodies. Each 
antigen has its own unique shape. 
2) Chemistry: Antigens are large molecules with a molecular weight greater than 
about 10,000. Most antigens consist of proteins or polysaccharides, but lipids and 
nucleic acids can also serve in this capacity. The ability of a molecule to function 
as an antigen depends not only on its size but also on its structure complexity. 
Therefore, proteins are more antigenic than the simpler structured polysaccharides. 
Example: Plastics used in artificial implants are composed of large molecules; yet 
they are not very antigenic due to their simple, repeating structures. 
3) Origin: Antigens include molecules belonging to viruses, bacteria, fungi, 
protozoa, and parasitic worms. They also mark the surfaces of foreign materials 
such as pollen and transplanted tissue. 
B. ANTIBODIES 
Antibodies (Ab) are proteins produced by B cells and the derived plasma cells. 
1) Chemical structure: 
• Antibodies consist of four polypeptide chains joined to form a Y -shaped 
molecule: two identical light chains and two identical heavy chains. Both 
heavy and light chains, covalently linked to each other by disulfide bonds 
(s-s), have 
CD Constant regions (Fe): so named because their sequences of amino acids 
vary little. 
Q) Variable regions (Fab): so named because their sequences of amino acids 
vary extensively. Variability of the antigen-binding regions is 
complementary for the specificity of antibodies for antigens. Thus, it is 
the variable region of an antibody that provides a specific site for bonding 
with a particular antigen. 
• There are two types of light chains, lambda (A) and kappa (~< ). In humans 
60% of the light chains are kappa and 40% are lambda. 
• Heavy chains serve to determine the functional activities of the antibody 
molecules. There are five types of heavy chains: IgA, IgD, IgE, IgG, and 
IgM. 
• The tail of the antibody molecule, consisting of the constant regions, is 
responsible for the antibody's effector mechanism by which it inactivates or 
helps destroy an antigenic invader. 
A Typical Antibody Structure: 
Heavy Chain ---+ 
Light Chain ---+ 
Antigen Binding 
Heavy Chain ---+ Biological Activity 
Constant regions 
Variable regions 
2) Classification: 
• Five different classes of immunoglobulins are identified: IgA, IgD, IgE, IgG, 
and IgM. 
• Different classes of antibodies have different heavy chains whose constant 
regions differ in length and sequence. The various antibodies appear at 
different times after exposure to an antigen and have different biological 
functions. 
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CD IgA: 
@IgD: 
Dimer 
13% of the total immunoglobulin (the 2nd most abundant Ig) 
Distribution: in tears, nasal mucus, breast milk, intestinal secretion 
Function: preventing viruses and bacteria from attaching to epithelial 
surfaces 
Monomer 
0.2% of the total immunoglobulin 
Distribution: in B-cell plasma membranes 
Function: probably functioning as an antigen receptor required for initiating 
the differentiation of B cells into plasma cells and memory B cells 
®IgE: 
® IgG: 
0:l IgM: 
Monomer 
0.002% of the total immunoglobulin 
Distribution: on mast cells and in saliva and nasal secretions 
Function: causing mast cells and basophils to release histamine and other 
chemicals, resulting in an allergic reaction as well as protecting 
against parasitic infections 
Monomer 
80% of the total immunoglobulin (the most abundant Ig) 
Distribution: equal intra- and extra vascular 
IgG can also cross the placenta and confer passive immunity from the 
mother to the fetus. 
Function: protecting against bacteria, viruses, and toxins circulating in the 
blood and lymph as well as triggering actions of the complement 
system 
Pentamer (the largest Ig) 
6% of the total immunoglobulin 
Distribution: in B-cell plasma membranes 
IgMs are the first circulating antibodies to appear in the early immune 
response. 
Functions: mediating initial immune response and activating bacterial-
killing complement 
3) Immunological functions: 
• B cells incorporate antibody molecules into their plasma membranes, where 
they serve as antigen receptors. 
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• Plasma cells secrete antibodies into the blood or other body fluids, 
where they serve against invading pathogens. 
• The bonding of antibodies to antigens does not cause destruction of the 
antigens directly. Rather, it is the basis of several effector mechanisms: 
CD Precipitation of soluble antigens 
al Agglutination of particulate antigens: immobilizing bacteria to stop 
their spread throughout the body 
@ Neutralization: blocking certain sites on antigen to make it ineffective 
** Note: The purpose for mechanism CD ~ @ is to enhance the phagocytosis 
by macrophages. The ability of antibodies to stimulate 
phagocytosis is termed opsonization. 
®Activation of complement: leading to cell lysis 
4) Genetics I Clonal Selection: 
• Genetics: 
CD Each heavy chain is coded for by four main DNA segments: a variable 
heavy (VH) segment, a diversity heavy (DH) segment, a joining heavy 
(JH) segment as well as a constant (C) region. Many thousands of 
different combinations are made through the process of splicing and 
recombination. 
@ A similar process of segment selection and recombination takes place to 
create the variable region of the light chains except that there are no D 
segments in the light chains. The kappa light chain is made of several 
V segments joining with five J segments and one C segment. The 
lambda light chain consists of two V segments combining with one J 
segment and several C segments. 
• Clonal selection: the explanation for cellular immunological specificity 
CD A single B lymphocyte can produce only one specific type of antibody 
for one antigenic target. 
al The specificity of lymphocytes to an antigen is predetermined during 
embryonic development before a contact with an antigen ever happens. 
Example: some lymphocytes can respond to smallpox and produce 
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antibodies against it even if the person has never been previously 
exposed to this disease. 
® The inherited specificity of each lymphocyte is reflected in the antigen 
receptor proteins on the surface of the lymphocyte's cell membrane. 
® According to the clonal selection theory, an antigen does not stimulate 
lymphocytes to produce the appropriate antibodies. Rather, it selects 
lymphocytes that are already able to make antibodies against that 
antigen. 
!51 Appendix -1: Graphic Presentation of Clonal Selection 
C. ANTIGEN-ANTIBODY INTERACTIONS 
• Generally, antibodies identify a particular region on the surface of an antigen 
called epitope. The binding takes place at the Fab region of an antibody. 
• Antigen-antibody interactions inactivate antigens by several ways: 
CD Precipitation of soluble antigens =t 
q) Agglutination of particulate antigens --> enhancing phagocytosis by 
@ Neutralization macrophages 
® Activation of complement ------------------> leading to cell lysis 
D. COMPLEMENT CHEMISTRY, FUNCTION, AND PATHWAYS 
1) Complement chemistry: The complement system is composed of at least 20 
proteins that are designated C1 (which has 3 protein components) through C9. 
These proteins are normally present in plasma and other body fluid. The 
complement system is an essential part of both the nonspecific and the specific 
defense systems. 
2) Function: The complement proteins can be classified into three components: 
recognition (C1), activation (C4, C2 & C3), and attack (C5- C9). 
Biological Effects of Complement: 
CD Opsonization: enhancing phagocytosis of cells (phagocytes have receptors for 
C3b) 
@ Chemotaxis: attracting neutrophils (C5a and C567 complex) 
@Anaphylatoxin: causing degranulation of mast cells (C3a, C4a, and CSa) 
5 
® Enhancement of Ab production (C3b) 
~ Cytolysis: leading to lysis of cells (C5b, C6, C7, C8, and C9 form a membrane 
attack complex which is present in both of the classical pathway and the 
alternative pathway) 
3) Pathways: 
• Classic Pathway: 
IgG and IgM that are attaching to antigens on the pathogen's cell membrane bind 
to Cl ~activated Cl catalyzes the hydrolysis of C4 into C4a & C4b ~ C4b 
binds to the cell membrane and becomes an active enzyme that splits C2 into C2a 
& C2b ~ the attachment C2a to C4b acts as C3/C5 convertase to cleave C3 into 
C3a & C3b ~ C3b converts C5 into C5a & C5b ~ C5b and C6~C9 eventually 
fix to the cell membrane and puncture the cell membrane ~ the osmotic influx of 
water causes the cell to swell and burst 
• Alternative Pathway: ** Abs are not required to active alternative pathway 
C3b from the classic pathway covalently binds to the pathogen surface ~ C3b 
binds to factor B ~bound factor B is cleaved by plasma protease factor D into 
Ba & Bb ~the complex of C3b and Bb acts as C3/C5 convertase to cleave many 
molecules of C3 into C3a & C3b ~ C3b contributes more production of C5b on 
the surface of the pathogen 
**The alternative pathway amplifies the effect of the classic pathway. 
E. CYTOKINES, ORGIN, AND FUNCTION 
1) Cytokines: proteins made by cells that affect the behavior of other cells. 
2) Origin: 
• Cytokines are produced primarily by leukocytes (white blood cells). 
• Cytokines produced by monocytes or macrophages are called monokines. 
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• Cytokines produced by lymphocytes are called lymphokines. 
• Cytokines include interleukins (ll..), interferons (IFN), tumor necrosis factors 
(TNF), and colony stimulating factors (CSF). 
• Each cytokine is secreted by a specific cell in response to a specific stimulus. 
3) Functions: 
• Cytokines help regulate B cells and T cells and thus play a pivotal role in both 
humoral and cell-mediated responses. 
• Cytokines bind to specific receptors on a target cell, generating an internal 
signal that alters the activity of the target cell. In responding to a cytokine, a 
target cell may prepare to divide, to differentiate, or to secrete its own 
cytokines. 
• Three different effects by cytokines: 
CD Autocrine effect: they affect the cells that produce them. 
<?> Paracrine effect: they affect other cells close to them. 
Q) Endocrine effect: they affect many cells systematically. 
F. NONSPECIFIC IMMUNITY 
1) Anatomical barriers: include skin and mucous membranes 
• The intact skin is a barrier that cannot be penetrated by bacteria or viruses. 
• Mucous membranes lining the digestive, respiratory, and genitourinary tracts 
prevent the entry of potentially harmful microbes. 
• In addition to their role as a physical barrier, the skin and mucous 
membranes also provide chemical defenses to pathogens. 
CD Secretions from oil and sweat glands give the skin a pH ranging from 
3 to 5, which is acidic enough to keep many microorganisms from 
colonizing. 
@ Saliva, tears, and mucous secretions contain various antimicrobial 
proteins such as lysozyme that can attack the cell walls of many 
bacteria. 
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2) Phagocytic cell types and inflammation: 
• Three major types of phagocytic cells: 
CD Polymorphomuclear neutrophils (PMN) 
- Arise in the bone marrow from a common stem cell and then undergo a 
series of divisions and maturation process to become mature PMN 
- Comprise about 60% to 70% of all white blood cells 
-Are short-living phagocytic cells; after about 7 hours in the blood, the 
PMNs enter the tissues where they complete their life span of a few days 
~ Monocytes 
- Arise in the bone marrow from a common stem cell 
- Comprise about 2% to 7% of the circulating blood leukocytes, providing 
an even more effective phagocytic defense 
-After maturing, monocytes circulate in the blood for 1 to 2 days, then 
migrate into tissues, enlarging, and developing into macrophages 
@ Macrophages 
- Are especially effective, long-living phagocytic cells 
- Some residing permanently in organs and connective tissues 
Example: Kuppfer's cells in the liver; the alveolar macrophages in the 
lungs and Langerhans cells in the skin, conjunctiva, and limbus. 
- Fixed macrophages are especially numerous in the lymph nodes and in 
the spleen, and others (also called histiocytes) migrate through all tissues 
of the body. 
• Functions of phagocytic cells: 
CD Polymorphomuclear neutrophils (PMN): the major defense against 
bacteria to engulf and kill the invading bacteria through phagocytosis; 
then they self-destruct that will be a major component of pus 
~ Monocytes: defending against bacteria, viruses, and protozoa to engulf and 
remove foreign materials through phagocytosis 
@ Macrophages: same as monocytes 
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** Note: 
a. Monocytes and neutrophils can be highly mobile within connective tissues as 
they scavenge for foreign invaders and cellular debris . 
b. Neutrophils arc the first to arrive the site of infection followed by monocytes 
that can be transformed into macrophages as the battle progresses. 
c. New phagocytic cells from the blood may join those already in the 
connective tissue. These new neutrophils and monocytes can squeeze 
through the tiny gaps between adjacent endothelial cells in the capillary and 
enter the connective tissues; this process is called diapedesis. 
d. The movement of additional phagocytic cells to an infected area in response 
to the release of chemical mediators by neutrophils, monocytes, and injured 
tissue is called chemotaxis. 
• Inflammation: 
G) Overview - - PATHOGENS INVADE TISSUES 
~ 
Cells injured 
~ 
Release histamine and other substances 
such as prostaglandins, leukotrienes, and bradykinin 
~ ~ ~ 
Blood vessels dilate 
due to histamine 
Capillaries become more permeable 
l 
Increased blood Antibodies 
flow to area pass from 
blood into 
inflamed area l \ ~ 
Bring *Redness 
needed 
phagocytes, 
nutrients, 
antibodies, 
etc. 
*Increased 
temp 
l 
*Edema 
*common clinical characteristics of inflammation 
\ 
*Pain 
Phagocytes migrate 
to injured region 
1 
Phagocytosis 
Release pyrogens 
(interleukin-1) 
l 
*Fever 
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@Sequence of events in local inflammatory response: 
a) Damaged to tissue by a physical injury or by the entry of microorganisms 
triggers an inflammatory response. 
b) Injured basophils and/or mast cells release histamine and other compounds 
that dilate blood vessels in the affected area and increase capillaries 
permeability, leading to ... 
• increasing blood flow to the infected region ~ redness and warmth 
• allowing more fluid to leave the blood and enter the tissues~ 
edema 
• delivering clotting elements into the injured area 
• allowing phagocytes to migrate from the blood into the injured 
tissues 
c) Neutrophils arrive at the injured site first, followed by monocytes to destruct 
pathogens. Neutrophils then self-destruct and monocytes clean up the 
remains of tissue cells. 
**Although inflammation is often a local response, sometimes the entire body is 
involved. White blood cells release cytokines called pyrogens that set the body's 
thermostat at a higher temperature. The most potent pyrogen is interleukin-1, 
released by macrophages. A short-term low fever can help speedy recovery by ... 
a) inhibiting the growth of some microorganisms by decreasing the 
amount of iron available to them 
b) facilitating phagocytosis 
c) promoting production of certain lymphocytes and antibodies 
3) Role of complement and antibody: 
• The complement system consists of at least 20 proteins that circulate in the 
blood in inactive state. These proteins act together in a cascade of activation 
steps. Two activation pathways are identified: classical pathway (acquired 
response) and alternative pathway (innate response). 
- The alternative pathway of complement action does not require 
cooperation with antibodies; thus the targets are not specific. 
[About pathways: see pg 6] 
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- Functions: 
a) Cytolysis: leading to lysis of cells by forming a membrane attack 
complex (MAC) 
b) Anaphylatoxin: causing degranulation of mast cells 
c) Opsonization: enhancing phagocytosis of cells (C3b is involved) 
d) Chemotaxis: attracting neutrophils 
• Opsonization, one of the functions of antibody, promotes phagocytosis. 
Phagocytes bear receptors for the Fe protion of the IgG molecule. This 
linkage helps attachment of the antigen to the phagocyte and triggers 
phagocytosis. 
4) Interferon, Lysozyme: 
• Interferons provide a nonspecific, short-acting resistance to viral infection. 
There are three major categories of interferons: 
Q) Interferon Alpha 
~ Interferon Beta 
- Secretion: (interferons alpha and beta) both by virally infected cells 
-Functions: (interferons alpha and beta) 
a) They act as antiviral agents that interfere with viral replication in 
the neighboring cells (therefore, an infected cell can help protect 
uninfected cells). The defense is not virus-specific; interferon 
produced in response to one viral strain provides resistance to 
unrelated viruses. 
b) They activate natural killer cells, which then kill virus-infected 
cells selectively. 
c) They induce Major Histocompatibility Complex (MHC) class I 
expression by most cells in the body. 
[About MHC: see pg 13] 
® Interferon Gamma 
- Secretion: by natural killer cells and helper T cells 
-Functions: 
a) It activates macrophages, enhancing their abilities to ingest and kill 
microorganisms. 
b) It activates natural killer cells. 
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c) It increases MHC expression by most cells in the body. 
• Lysozyme, an enzyme found in tears, saliva, and sweat, digests the cell walls 
of many bacteria. 
5) Natural killer (NK) cells: 
• NK cells are lymphocytes that can kill tumor cells and virus-infected cells in a 
nonspecific fashion. Their activity is stimulated by interferon. 
• NK cells selectively kill target cells without MHC class I molecules. 
• The mode of destruction is not phagocytosis but the release of substances, 
which produce lesions in the membranes of target cells (cytotoxicity). 
• The cytotoxicity is "natural" or "innate", which means NK cells do not 
require prior exposure for sensitization to the antigens. 
G. SPECIFIC IMMUNITY 
1) Cell types, markers and function: 
• Cell types: including lymphocytes and phagocytes 
CD B lymphocytes: mediate humoral immunity 
- developed from the lymphocytes remaining in the bone marrow 
**Lymphocytes originate from stem cells in the bone marrow, or in the 
fetus, mainly in the liver. They are initially alike, but later differentiate 
into B or T cells, depending on where they continue their maturation. 
- most concentrated in lymph nodes, the spleen, and other lymphatic 
organs after maturation 
- equipped with antigen receptors that are actually membrane-bound 
antibody molecules specific for a certain antigen 
- can differentiate into memory B cells and plasma cells 
CD T lymphocytes: mediate cellular immunity 
- developed from the lymphocytes migrating from the bone marrow to the 
thymus 
- most concentrated in lymph nodes, the spleen, and other lymphatic organs 
after maturation 
- equipped with specific antigen receptors that recognize antigens 
specifically 
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- four varieties: helper T cells, suppressor T cells, cytotoxic or killer T cells, 
and memory T cells 
® Macrophages 
- secrete interleukin-1 that helps activate B cells and helper T cells 
-engulf some of the bacteria and display fragments of bacterial antigens on 
the cell surface to activate helper T cells 
• Markers: 
-Anti-immunoglobulin antibody can be used to distinguish B lymphocytes 
from T lymphocytes. 
- Anti-T-cell receptor antibody can be used to mark T lymphocytes. The 
two main surface markers are defined: CD4 on helper T cells and CD8 on 
killer T cells (CD= clusters of differentiation). 
- In normal healthy individuals, the ratio of CD4 to CDS is about 2:1. 
- Major Histocompatibility Complex (MHC): a group of protein marker 
enables the immune system to distinguish self from nonself. In human, it 
is also called the HLA (human leukocyte antigen) group. The MHC 
consists of at least twenty different genes, most of which are highly 
polymorphic. Thus, it is virtually impossible that any two people in a 
population have the same HLA alleles. The MHC is divided into two 
major groups: 
a) MHC class I molecules: are found on most nucleated cells and are 
important in distinguishing between self and 
nonself. 
b) MHC class II molecules: are found only on cells of the immune system, 
including macrophages, B cells and activated 
T cells and are important in interactions 
between cells of the immune system. 
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T Lymphocytes in association with MHC Proteins: 
CD 4 coreceptor 
macrophage 
CD 8 coreceptor 
Target cell 
Helper 
T cell 
Killer 
T cell 
Helper T cell can interact 
only with MHC class II 
molecule. 
Killer T cell can interact 
only with MHC class I 
molecule. 
The CD4 and CD8 coreceptor permit the T lymphocyte receptors to interact with only a 
specific class of MHC molecule. 
- Three genes, HLA-A, HLA-B as well as HLA-C, code for the MHC class 
I molecules. There are 23 different alleles for the A locus, 49 for the B 
locus, and 8 for the C locus. 
- Several HLA-D (DP, DQ, and DR) code for the MHC class II molecules. 
- Any individual inherits a single allele at each locus from each parent. 
Consequently, only two class-I and two class-II MHC molecules are made 
at each locus. The expression of these genes is codominant. Totally, there 
are 12 HLA proteins (3 at class I loci and 3 at class II loci from both 
chromosomes) that can be made by each individual. 
• Function: 
Specific immunity involves the functions of lymphocytes and is directed 
only against specific molecules present in the foreign material. In addition, 
several days may be required to activate specific immune responses that 
consist of two main types: 
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CD Humoral immunity in which lymphocytes produce specific antibodies 
designed to identify and to destroy pathogens 
<I> Cellular immunity in which lymphocytes attack the invading pathogens 
directly 
2) Cell-cell interactions in the immune response: 
• The macrophage takes the antigen and cleaves it into fragments, which will be 
displayed on the cell surface. 
• The receptor of a helper T cell can recognize the ..MHC class II-antigen 
complex displayed on the surface of the macrophage. This interaction 
enhanced by CD4 activates the T cell. Meanwhile, the macrophage is 
stimulated to secret interleukin-1. This signals the helper T cell to release 
interleukin-2 which stimulates helper T cells to grow and divide more rapidly, 
increasing the supply of both helper T cells and interleukin-2. 
• The activated helper T cell will 
CD interact with a B cell that has taken in antigens and displays a 
fragment of the antigen along with MHC class II molecule. The B cell is 
activated by interleukin-4 and interleukin-5 released by the activated 
helper T cell. 
<I> release interleukin-2 and other cytokines to stimulate killer T cells 
whose receptors have recognized the ..MHC class !-antigen complex on 
the surface of an infected cell or cancer cell; the interaction between a 
killer T cell and an infected cell is enhanced by CD8. 
a Appendix-2: A Summary of Cell-Cell Interactions 
a Appendix-3: Graphic Presentation of Interactions of Macrophages, Helper T cells, 
and B cells 
a Appendix-4: Graphic Presentation of Interactions of Macrophages, Helper T cells, 
and Killer T cells 
3) Humoral immunity: 
Humoral immunity results in the production of specific antibodies that defend 
mainly against toxins, free bacteria, and viruses present in blood fluids. 
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• The activation of B cells: 
In most cases, the activation of B cells triggered by antigen requires helper 
T cells. Thus, a two-step process is involved: 
CD binding of antigen to specific receptors (membrane-bound antibodies) 
on the surface of a B cell directly. 
CD B cell with MHC class ll -antigen complex binding to activated 
helper T cell that meanwhile secretes interleukin-4 and interleukin-5 
to assist activation. 
[About activation of helper T cells: see pg 14] 
However, a few antigens such as the polysaccharides present in bacterial 
cell walls, can activate B cells by themselves so only step CD is involved. 
• The result of activation: 
Once activated, B cells increase in size and divide by mitosis, forming a 
clone of cells with the same specificity. Some of these B cells mature into 
plasma cells that secrete antibody. And, some differentiate into memory 
cells that continue to produce small amounts of antibody long after an 
infection has been overcome. 
[About antibody: see pg 1-3] 
[Graphic presentation ofB cells activation: see appenclix-3] 
4) Cellular immunity: 
Cellular immunity is mediated by T lymphocytes that are against bacteria and 
viruses inside the host cells. Furthermore, T lymphocytes are also involved in 
attacks on transplanted tissue and cancer cell. 
• Types and Functions ofT cells: 
CD Helper T cells (CD4): releasing ... 
- interleukin-2: activating the antigen-specific helper T cell to produce a 
clone of these cells and to activate B cells 
- interlukin-4 and interlukin-5: activating killer T cells 
-gamma interferon: activating macrophages (type 4 hypersensitivity) 
CD Killer T cells (CDS): releasing ... 
- perofrins: killing allograft cells, virus-infected cells, and cancer 
cells by puncturing holes in the cell membrane 
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al Suppressor T cells (CD4 and CDS) 
- Decreasing or stopping the activities of the other T cells and B cells 
® Memory T cells (long-lived CD4s and CD8s): 
- Triggering an immune reaction quickly so that an infection will not 
be clinically apparent 
** Note: IDV selectively infects and destroys helper T cells. AIDS is 
diagnosed when CD4level is lower than 200/dL (normally, it is 1000 
T cells/dL in blood). 
• The activation ofT cells: 
CD Helper T cells: they only respond to antigen presented to them by 
macrophages in combination with a MHC class II 
molecule. 
The activation involves two signals: 
a) binding with antigen-presenting macrophages 
b) interleukin-1 released by the macrophages 
[Graphic presentation of helper T cells activation: see appendix-3] 
@ Killer T cells: the activation involves two signals: 
a) recognition by a killer T cell of an antigen in 
combination with a MHC class II molecule on the 
surface of another cell 
b) interleukin-2 released by an activated helper T cell. 
[Graphic presentation of killer T cells activation: see appendix-4] 
5) Primary and secondary immune response: 
• Primary immune response: is stimulated by the first exposure to an antigen. 
CD Latent phase: 
-generally takes 1-2 weeks 
- during this lag period, the antigen is recognized and lymphocytes begin 
to from clones and to undergo differentiation as well . 
17 
a> Exponential production phase: 
- antibody concentration rises exponentially for several days until it 
reaches a peak. IgM is principle antibody synthesized; if IgG is made, 
the production of IgM ceases. 
(J) Steady state phase: 
- Production and degradation of antibody are balanced. 
® Declining phase: 
- Immune response shuts down and antibody concentration decreases to a 
very low level. 
• Secondary immune response: is mediated by long-lived memory cells, which 
are produced along with the relatively short-lived effector cells of the primary 
immune response. These memory cells are inactive during the primary 
immune response. Yet, they survive for a long period of time and proliferate 
rapidly when exposed again to the same antigen that caused their formation . 
- a shorter lag time which is about 3-5 days 
- the amount of antigen necessary to evoke a secondary response is much 
less than that needed for a primary response. 
- production of antibody is greater than in a primary response and continues 
over a longer period of time; also, the decline phase is slower. 
- IgG is the predominant antibody, produced at higher concentration and 
with greater persistence than IgM. 
Kinetics of the Immune Response: 
Serum ('. 
[Ab] ~==========~;/\_ \ 
t 10 days 
antigen 1st exposure 
/,..--- lgG 
R lgM 
t 3 days 
antigen 2nd exposure 
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H. TISSUE TRANSPLANTATION AND GRAFT REJECTION (MECHANISMS) 
• Autograft, a procedure in which tissue transplanted from one location to 
another in the same individual, is always accepted. A syngeneic graft 
between identical twins is usually accepted. Yet, an allograft between one 
person and another yields a variable degree of rejection. 
• Graft rejection is an immune response against transplanted tissue and is due to 
highly polymorphic MHC (major histocompatibility complex) molecules 
among different individuals. Recall the antigens of the MHC are described as 
class I and class II. Class I antigens are found on all nucleated cells. And, 
class II antigens are found mainly on B ce11s and macrophages. If a donor 
organ is only slightly different from a recipient in the MHC class I proteins, 
the degree of similarities of the class II proteins determines if a major 
rejection will occur. 
• Foreign HLA antigens can be present within the grafted organ or can be 
carried to the regional lymph nodes, causing killer T cells to launch a cell-
mediated response against the donated tissue or organ. 
• T cells usually play a major role in transplanted rejection. However, humoral 
responses can also contribute to the graft rejection by complement-dependent 
cytotoxicity, antibody-dependent cell mediated cytolysis and the deposition of 
antigen-antibody complexes. The various contributions of cell-mediated 
immunity and humoral immunity differ among grafts and are often reflected 
in the histologic features of the rejected organs. 
• In order to minimize graft rejection: 
CD The MHC proteins of the organ donor and recipient must be matched as 
closely as possible. 
Cl> Various drugs such as azathioprine, corticosteroids, cyclosporine, and 
antilymphocyte antibodies are used. Unfortunately, these drugs tend to 
compromise the immune system, increasing the risk of organ recipient to 
cancer and infections. 
• Note that the body' s response due to a transplanted organ is not a disorder of 
the immune system, but a normal action taken by a healthy immune system 
exposed to foreign antigens. 
• Note that corneas are easily grafted because they are avascular with no 
lymphatic system. 
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I. AUTOIMMUNITY 
• Immunological tolerance: refers to a specific non-responsiveness to an 
antigen. The immune system is selectively tolerant to our own individual 
tissues and cells. Two general theories have been proposed to explain 
tolerance: 
CD Clonal deletion theory: tolerance is acquired by destruction of the 
lymphocytes that recognize self-antigens. This mechanism is believed 
to be largely responsible forT cell tolerance and occurs mainly during 
fetal life. 
@ Clonal anergy: tolerance is acquired by inactivation of the lymphocytes 
that can act against self-antigens; these lymphocytes are present 
throughout life but do not attack the self-antigens. It is believed to be 
largely responsible forB cell tolerance. 
• Autoimmunity: is a result of a breakdown of natural tolerance to "self' 
tissue or component. 
Type of Immune 
Response 
Antibody to 
Receptors 
Antibody to Cell 
Components 
Autoimmune Disease 
a) Myasthenia gravis 
b) Graves'disease 
c) Insulin-resistant diabetes 
a) Systemic lupus erythematosus 
b) Rheumatoid arthritis 
c) Rheumatic fever 
d) Hashimoto's thryroiditis 
e) Insulin-dependent diabetes 
f) Guillain-Barre syndrome 
g) Acute gomerulonephritis 
Target of 
Immune Response 
Acetylcholine receptor 
TSH receptor 
Insulin receptor 
DsDNA, histones 
IgG in joints 
Heart and joint tissue 
Thyroglobulin 
Islet cells 
Mylein protein 
Glomerular basement 
membrane 
20 
• Mechanisms for autoimmunity 
CD If the antigens of sequestered tissues are exposed to antibodies, an 
immune response may be triggered. 
Example: in Hashimoto's thyroiditis, thyroglobulin that is normally 
sequestered within the thyroid follicles can simulate 
autoantibodies to attack the thyroid. 
@ If cross reactions between self and non-self antigens occur, tolerance can 
be terminated. 
Example: in rheumatic fever, antibodies produced to against 
streptococcal infection can cross-react with heart tissue. 
a> If the functions of suppressor T cells decrease, antibodies may be 
formed to attack other antibodies. 
Example: in rheumatoid arthritis, the inflammation reaction of the 
joints is contributed by IgM antibodies against IgG antibodies. 
@)Antibodies or T cells produced in response to foreign antigens may cross-
react with self antigens, owing to a phenomenon called "molecular 
mimicry". 
Example: in glomerulonephritis, antibodies produced in response to 
Streptococcus bacterial infection can cause damage to the 
glomerular capillaries in the kidneys. 
J. TUMOR IMMUNOLOGY 
• Tumor Cells and Immune Response: It is believed that tumor cells express 
antigens recognizable by the immune system. The cells involved in 
fighting tumors are 
CD Killer T cells: can target tumor cells and lyse them. 
@Natural killer cells: can kill tumor cells, which have low MHC class I 
molecules on the surface. 
If the immune response to these antigens does not occur or does not 
successfully eliminate the tumor, disease results. 
• Immunosurveillance: the ability of the immune system to detect and to destroy 
tumor cells. This concept explains why patients with AIDS or those receiving 
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immunosuppressive drugs have a greater risk to cancer. However, the 
immunosurveillance concept is still currently controversial since cancer is a 
common disease in otherwise immunocompetent patients. Yet, in order to 
grow progressively, tumor cells must be able to escape destruction by the 
immune system. 
• How do tumors avoid immune attack? 
CD Low immunogenicity: tumor cells may lose expression of 
histocompatibility antigen and therefore appear normal to the immune 
system. 
@Antigenic modulation: tumor cells may initially express antigens that can 
be recognized by the immune system but then lose them due to antigenic 
variation. 
®Tumor-induced immune suppression: tumor cells often produce 
substances that can suppress immune responses directly. 
• Immune Therapy of Cancer: 
CD Interferons are an effective tool in the treatment of particular forms of 
cancer. 
@ Interleukin-2 can activate both killer T cells and B cells. A group of 
lymphocytes are isolated from blood sample of the patient and combined 
with IL-2 to produce lymphokine-activated killer (LAK) cells. Then, 
these LAK cells with IL-2 as well as interferons are infused into the 
patient. 
® Tumor-infiltrating lymphocyte (TIL) are identified for their ability to 
invade solid tumors in mice. Being combined with Interleukin-2, they 
have shown some hopeful results on humans. However, the long-
term effects of the treatment are not known at the present time. 
K. IMMUNOLOGICAL TESTS 
• Erythrocyte sediment rate (ESR): is used to determine the presence of 
inflammation by measuring the rate of fall of red blood cells. The higher 
the rate, the greater the amount of inflammation. 
• Human leukocyte antigen (HLA): is used to determine the presence of 
certain "genetic markers" in the blood. For instance, B-27 is a genetic 
marker that are found in most patients with ankylosing spondylitis and 
Reiter's syndrome. 
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• Rheumatoid factor (RF): is used to determine whether a certain amount of 
abnormal antibody called rheumatoid factor is in the blood. It is positive in 
rheumatic arthritis, lupus, sarcoid etc. A positive rheumatoid factor can be 
helpful in the diagnosis, but the test alone is not conclusive. 
• Enzyme-linked immunosorbent assay (ELISA): is used to detect certain 
bacterial antigens, antibodies, and hormones as well. It is frequently 
applied in the initial screening for AIDS. 
• Antinuclear antibody (ANA): is used to detect the presence of 
autoantibodies that can react with antigens in the nuclei of cells. 
Autoantibodies are found in people with lupus, scleroderma and 
rheumatoid arthritis. 
• Acetylcholine receptor antibody: is used to detect the presence of 
antibodies that can act against acetylcholine receptors, an event occurring 
in the disease myasthenia gravis. 
• Tissue Biopsy: is used to confirm a diagnosis or check on the status of 
disease activity. 
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